THE MCMANUS GROUP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA approval and enforcement issues. PDUFA reauthorization. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Medicare coverage and payment of Part B drugs and biologicals.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.